Endocrinology

Blended Learning Journey Diabetes 2024


from 15 May to 18 October 2024

Overview

Hyperglycemia, pre-diabetes and undiagnosed type 2 diabetes mellitus are growing global health problems. Although people can live with hyperglycemia without overt symptoms, it increases the risk of developing serious health conditions and for premature death. Hyperglycemia in prediabetes and type 2 diabetes is reversible if the patient is able and willing to adopt lifestyle recommendations. Screening at-risk populations is crucial for providing affected individuals with information and help that reduces, or prevents, escalation of their condition. Screening, preventative and best practice care and personalization of treatment are also important for diabetic-related foot disease. The current lifetime risk of diabetic foot ulcer for those with diabetes is 19–34 and the 5-year mortality rate is 50–70% (McDermott, 2023). The amputation incidence is increasing particularly in the young and in racial and ethnic minority populations; all statistics are strongly linked to poor diabetes management (McDermott, 2023). Screening and care for women of child-bearing age with diabetes, especially during pre-pregnancy and pregnancy, is a widening practice gap, as is the ongoing care of women who experience diabetes during pregnancy and who are then at increased risk of developing diabetes in later life.

Learning Objectives

At the end of the blended learning journey, participants should be able to:

Target Audience

Clinicians involved in endocrinology, particularly diabetes, pre-diabetes; fertility and pregnancy management, obesity management and general practice; some content of interest to midwives and nurses involved in pre-natal and post-natal care; some content of interest to vascular specialists and podiatrists.

Language

The official language of this educational programme will be English. Simultaneous translation into Spanish and Chinese will be provided.

Continuing Medical Education
(CME)

The BLENDED LEARNING JOURNEY ON DIABETES AND PRE-DIABETES 2024 will be submitted for CME accreditation from the European Accreditation Council for Continuing Medical Education (EACCME), the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) and for Continuing Professional Development (CPD) credits.

Blended Learning Journey on Diabetes and Pre-diabetes 2024

from 15 May to 18 October 2024

E-learning Activities

E-learning Activities

This learning journey is a structured educational programme comprising:

Video Presentation

LAUNCH 15 MAY 2024

Ideal practice for personalized treatment of patients with type 2 diabetes

Podcast & Infographic

LAUNCH 15 July 2024

Best Screening for type 2 diabetes

Podcast & Infographic

LAUNCH 16 September 2024

Diabetes-related foot disease

CME Live Webinar

LAUNCH 18 October 2024

Hyperglycemia in pregnancy and beyond

Final Programme

Download STD & Scientific Programme

Save the Date
Programme soon

PDF